Catecho-O-methyltransferase inhibitors in Parkinson's disease [5]

Lancet

Volumn 352, Issue 9127, 1998, Pages 578-

  Harper, J ^a   Vieira, B ^a  

^a Osborne Park Hospital   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE INHIBITOR; LEVODOPA; TOLCAPONE; ANTIPARKINSON AGENT; BENZOPHENONE DERIVATIVE; CATECHOL METHYLTRANSFERASE; ENZYME INHIBITOR; NITROPHENOL;

AGED; CONFUSION; HUMAN; LETTER; PARKINSON DISEASE; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG INTERACTION; DYSKINESIA; NOTE;

AGED; ANTIPARKINSON AGENTS; BENZOPHENONES; CATECHOL O-METHYLTRANSFERASE; CONFUSION; DRUG INTERACTIONS; DYSKINESIA, DRUG-INDUCED; ENZYME INHIBITORS; HUMANS; LEVODOPA; NITROPHENOLS; PARKINSON DISEASE;

EID: 0032528718     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79290-4     Document Type: Letter

References (2)

1. C Henry JA Wilson Catechol-O-methyltransferase inhibitors in Parkinson's disease Lancet 351 1998 1965 1966
2. JG Nutt Catechol-O-methyltransferase inhibitors for treatment of Parkinson's disease Lancet 351 1998 1221 1222